Rising Cancer Incidence Drives Surge In Circulating Tumor Cells Market: Powering Innovation and Expansion in the Circulating Tumor Cells Market by 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Circulating Tumor Cells Market Through 2025?
In recent times, there has been a swift expansion in the size of the circulating tumor cells market. It is projected to enlarge from its 2024 value of $11.9 billion to reach $13.27 billion in 2025, marking a compound annual growth rate (CAGR) of 11.5%. Factors contributing to the growth in this historic stage include the rising incidence and prevalence of cancer, the clinical application of cancer staging, the emergence of liquid biopsy, patient preference for less invasive tests, regulatory backing for liquid biopsies, and the emphasis on identifying cancer in its early stages.

What's the Projected Size of the Global Circulating Tumor Cells Market by 2029?
In the coming years, the market size of circulating tumor cells is predicted to undergo swift expansion. By 2029, it is projected to reach a value of $21.38 billion, with a compound annual growth rate (CAGR) of 12.7%. This expected growth during the forecast period will likely be driven by factors such as the utilization of point-of-care CTC testing, the adoption of microfluidics, the focus on rare cancer variations, standardization of CTC tests, expansion of clinical trials based on CTC, and the growth of the economy and emerging markets. Key trends for the forecast period encompass innovative methods for isolating CTCs, government-backed CTC research initiatives, advancements in CTC detection technology, the use of liquid biopsy for cancer surveillance, integration with single-cell analysis, and the technological fusion with artificial intelligence (AI).

View the full report here:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Top Growth Drivers in the Circulating Tumor Cells Industry: What's Accelerating the Market?
The escalating prevalence of cancer is predicted to drive growth in the circulating tumor cells market. Cancer is characterized by the unregulated growth and spread of certain body cells. Circulating tumor cells aid in early cancer detection and diagnosis, so the rise in cancer rates propels their market growth. For instance, the American Cancer Society Journals, a voluntary health organization based in the US, estimated in January 2023 that there would be 1,958,310 new diagnoses of cancer, with an anticipated 609,820 cancer-related fatalities in the United States. As such, the increasing occurrence of cancer serves as a significant factor propelling the expansion of the circulating tumor cells market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Long-Term Trends Will Define the Future of the Circulating Tumor Cells Market?
Emerging trends within the circulating tumor cells market highlight a significant focus on product innovation. To secure their market dominance, many leading companies are prioritising the development of innovative solutions. For example, Bio-Rad Laboratories, Inc. of the USA launched Celselect Slides 2.0 in June 2024. This product was engineered to improve the capture of rare cells and circulating tumor cells (CTCs) thereby increasing the precision and effectiveness of cell analysis in both clinical settings and research applications.

What Are the Main Segments in the Circulating Tumor Cells Market?
The circulating tumor cells market covered in this report is segmented -

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Which Top Companies are Driving Growth in the Circulating Tumor Cells Market?
Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Which Regions Will Dominate the Circulating Tumor Cells Market Through 2029?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.